The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Contemporary Management of Chronic Obstructive Pulmonary Disease: Scientific Review
Open accessAbstract
CONTEXT: The care of patients with chronic obstructive pulmonary disease (COPD) has changed radically over the past 2 decades, and novel therapies can not only improve the health status of patients with COPD but also modify its natural course. OBJECTIVE: To systematically review the impact of long-acting bronchodilators, inhaled corticosteroids, nocturnal noninvasive mechanical ventilation, pulmonary rehabilitation, domiciliary oxygen therapy, and disease management programs on clinical outcomes in patients with COPD. DATA SOURCES: MEDLINE and Cochrane databases were searched to identify all randomized controlled trials and systematic reviews from 1980 to May 2002 evaluating interventions in patients with COPD. We also hand searched bibliographies of relevant articles and contacted experts in the field. STUDY SELECTION AND DATA EXTRACTION: We included randomized controlled trials that had follow-up of at least 3 months and contained data on at least 1 of these clinical outcomes: health-related quality of life, exacerbations associated with COPD, or death. For pulmonary rehabilitation, we included studies that had a follow-up of at least 6 weeks. Using standard meta-analytic techniques, the effects of interventions were compared with placebo or with usual care. In secondary analyses, the effects of interventions were compared against each other, where possible. DATA SYNTHESIS: Long-acting beta2-agonists and anticholinergics (tiotropium) reduced exacerbation rates by approximately 20% to 25% (relative risk [RR] for long-acting beta2-agonists, 0.79; 95% CI, 0.69-0.90; RR for tiotropium, 0.74; 95% CI, 0.62-0.89) in patients with moderate to severe COPD. Inhaled corticosteroids also reduced exacerbation rates by a similar amount (RR, 0.76; 95% CI, 0.72-0.80). The beneficial effects were most pronounced in trials enrolling patients with FEV1 between 1 L and 2 L. Combining a long-acting beta2-agonist with an inhaled corticosteroid resulted in an approximate 30% (RR, 0.70; 95% CI, 0.62-0.78) reduction in exacerbations. Pulmonary rehabilitation improved the health status of patients with moderate to severe disease, but no material effect was observed on long-term survival or hospitalization rates. Domiciliary oxygen therapy improved survival by approximately 40% in patients with PaO2 lower than 60 mm Hg, but not in those without hypoxia at rest. The data on disease management programs were heterogeneous, but overall no effect was observed on survival or risk of hospitalization. Noninvasive mechanical ventilation was not associated with improved outcomes. CONCLUSIONS: A significant body of evidence supports the use of long-acting bronchodilators and inhaled corticosteroids in reducing exacerbations in patients with moderate to severe COPD. Domiciliary oxygen therapy is the only intervention that has been demonstrated to prolong survival, but only in patients with resting hypoxia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Jaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa030287 · Cited by 2,071
Multiple Risk Factor Intervention Trial: Risk Factor Changes and Mortality Results
(1982) · JAMA · doi:10.1001/jama.1982.03330120023025 · Cited by 1,722
A measure of quality of life for clinical trials in chronic lung disease
Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987) · Thorax · doi:10.1136/thx.42.10.773 · Cited by 1,721
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Anthonisen, N. R. (1994) · JAMA · doi:10.1001/jama.1994.03520190043033 · Cited by 1,341
Self-citationCalverley, P., Pauwels, R., Vestbo, J., Jones, P., Pride, N., Gulsvik, A., Anderson, J., & Maden, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12459-2 · Cited by 1,221
Sin, D. D., & Man, S. F. P. (2003) · Circulation · doi:10.1161/01.cir.0000056767.69054.b3 · Cited by 1,082
Self-citationPauwels, R. A., Löfdahl, C.-G., Laitinen, L. A., Schouten, J. P., Postma, D. S., Pride, N. B., & Ohlsson, S. V. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402503 · Cited by 1,074
Nicotine replacement therapy for smoking cessation
Silagy, C., Lancaster, T., Stead, L., Mant, D., & Fowler, G. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub2 · Cited by 972
Griffiths, T., Burr, M., Campbell, I., Lewis-Jenkins, V, Mullins, J., Shiels, K., Turner-Lawlor, P., Payne, N., Newcombe, R., Lonescu, A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)07042-7 · Cited by 952
Bourbeau, J. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.5.585 · Cited by 939
Ries, A. L., Kaplan, R. M., Limberg, T. M., & Prewitt, L. M. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-11-199506010-00003 · Cited by 903
Szafranski, W., Cukier, A., Ramirez, A., Menga, G., Sansores, R., Nahabedian, S., Peterson, S., & Olsson, H. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00031402 · Cited by 887
(1981) · The Lancet · doi:10.1016/s0140-6736(81)91970-x · Cited by 884
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Casaburi, R., Mahler, D. A., Jones, P. W., Wanner, A., San Pedro, G., ZuWallack, R. L., Menjoge, S. S., Serby, C. W., & Witek, T. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00269802 · Cited by 881
Govaert, T. M. E. (1994) · JAMA · doi:10.1001/jama.1994.03520210045030 · Cited by 867
(2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432601 · Cited by 830
Vestbo, J., Søorensen, T., Lange, P., Brix, A., Torre, P., & Viskum, K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10019-3 · Cited by 816
Does Increased Access to Primary Care Reduce Hospital Readmissions?
Weinberger, M., Oddone, E. Z., & Henderson, W. G. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342206 · Cited by 800
Nichol, K. L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., & Iwane, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025028 · Cited by 752
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
Vincken, W., van Noord, J. A., Greefhorst, A. P. M., Bantje, T. A., Kesten, S., Korducki, L., & Cornelissen, P. J. G. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00238702 · Cited by 736
Weingarten, S. R. (2002) · BMJ · doi:10.1136/bmj.325.7370.925 · Cited by 735
Antidepressants for smoking cessation
Hughes, Jr., Stead, L., & Lancaster, T. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031 · Cited by 681
Patients at High Risk of Death after Lung-Volume–Reduction Surgery
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa11798 · Cited by 634
Burden of Disease—Implications for Future Research
Michaud, C. M. (2001) · JAMA · doi:10.1001/jama.285.5.535 · Cited by 594 · cited 1×
“Although COPD is currently the 4th-leading cause of mortality and the 12th-leading cause of disability, by the year 2020 it is estimated that COPD will be the 3rd-leading cause of death and the 5th-leading cause of disability worldwide.(3,4) In 1993, the total economic costs of COPD were estimated to be $24 billion in…”
BackgroundHospitalizations and Mortality in the Lung Health Study
Anthonisen, N. R., Connett, J. E., Enright, P. L., & Manfreda, J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2110093 · Cited by 588
Self-citationInterpreting thresholds for a clinically significant change in health status in asthma and COPD
Jones, P. W. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00063702 · Cited by 585
Sullivan, S. D., Ramsey, S. D., & Lee, T. A. (2000) · Chest · doi:10.1378/chest.117.2_suppl.5s · Cited by 579
Health status measurement in chronic obstructive pulmonary disease
Jones, P. W. (2001) · Thorax · doi:10.1136/thorax.56.11.880 · Cited by 557
Randomised controlled trial of respiratory rehabilitation
GOLDSTEIN, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90568-1 · Cited by 541
Troosters, T., Gosselink, R., & Decramer, M. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00472-1 · Cited by 525
Efficacy of Salmeterol Xinafoate in the Treatment of COPD
Mahler, D. A., Donohue, J. F., Barbee, R. A., Goldman, M. D., Gross, N. J., Wisniewski, M. E., Yancey, S. W., Zakes, B. A., Rickard, K. A., & Anderson, W. H. (1999) · Chest · doi:10.1378/chest.115.4.957 · Cited by 520
Paggiaro, P. L., Dahle, R., Bakran, I., Frith, L., Hollingworth, K., & Efthimiou, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)03471-5 · Cited by 508
Mahler, D. A., Wire, P., Horstman, D., Chang, C.-N., Yates, J., Fischer, T., & Shah, T. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112055 · Cited by 495
Quality of life changes in COPD patients treated with salmeterol.
Jones, P. W., & Bosh, T. K. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.4.9105068 · Cited by 494
Meecham Jones, D. J., Paul, E. A., Jones, P. W., & Wedzicha, J. A. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.2.7633704 · Cited by 479
Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease
Hosenpud, J. D., Bennett, L. E., Keck, B. M., Edwards, E. B., & Novick, R. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06405-2 · Cited by 472
Airways Obstruction and the Risk for Lung Cancer
TOCKMAN, M. S., ANTHONISEN, N. R., WRIGHT, E. C., & DONITHAN, M. G. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-4-512 · Cited by 472
Self-citationDonohue, J. F., van Noord, J. A., Bateman, E. D., Langley, S. J., Lee, A., Witek, T. J., Kesten, S., & Towse, L. (2002) · Chest · doi:10.1378/chest.122.1.47 · Cited by 471
Self-help interventions for smoking cessation
Lancaster, T., & Stead, L. F. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001118.pub2 · Cited by 463
Clini, E., Sturani, C., Rossi, A., Viaggi, S., Corrado, A., Donner, C. F., & Ambrosino, N. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.02162001 · Cited by 447
Arcasoy, S. M., & Kotloff, R. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904083401406 · Cited by 443
Brusasco, V (2005) · Thorax · doi:10.1136/thx.2005.brusascolett · Cited by 431
(1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.5.ats2-99 · Cited by 425
Long-term Effects of Outpatient Rehabilitation of COPD
Güell, R., Casan, P., Belda, J., Sangenis, M., Morante, F., Guyatt, G. H., & Sanchis, J. (2000) · Chest · doi:10.1378/chest.117.4.976 · Cited by 420
CULPITT, S. V., MAZIAK, W., LOUKIDIS, S., NIGHTINGALE, J. A., MATTHEWS, J. L., & BARNES, P. J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.5.9811058 · Cited by 417
Brusasco, V (2003) · Thorax · doi:10.1136/thorax.58.5.399 · Cited by 409
Effect of Lung-Volume–Reduction Surgery in Patients with Severe Emphysema
Geddes, D., Davies, M., Koyama, H., Hansell, D., Pastorino, U., Pepper, J., Agent, P., Cullinan, P., MacNeill, S. J., & Goldstraw, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430402 · Cited by 399
Maintenance after Pulmonary Rehabilitation in Chronic Lung Disease: A Randomized Trial
Ries, A. L., Kaplan, R. M., Myers, R., & Prewitt, L. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-318oc · Cited by 371
Gorecka, D., Gorzelak, K., Sliwinski, P., Tobiasz, M., & Zielinski, J. (1997) · Thorax · doi:10.1136/thx.52.8.674 · Cited by 371
Inhaled Formoterol Dry Powder Versus Ipratropium Bromide in Chronic Obstructive Pulmonary Disease
DAHL, R., GREEFHORST, L. A. P. M., NOWAK, D., NONIKOV, V., BYRNE, A. M., THOMSON, M. H., TILL, D., & DELLA CIOPPA, G. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.5.2007006 · Cited by 358
Wedzicha, J., Bestall, J., Garrod, R., Garnham, R., Paul, E., & Jones, P. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12020363 · Cited by 352
Casanova, C., Celli, B. R., Tost, L., Soriano, E., Abreu, J., Velasco, V., & Santolaria, F. (2000) · Chest · doi:10.1378/chest.118.6.1582 · Cited by 350
Hemodynamic Response to Oxygen Therapy in Chronic Obstructive Pulmonary Disease
TIMMS, R. M., KHAJA, F. U., & WILLIAMS, G. W. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-1-29 · Cited by 341
Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation.
Simpson, K., Killian, K., McCartney, N., Stubbing, D. G., & Jones, N. L. (1992) · Thorax · doi:10.1136/thx.47.2.70 · Cited by 337
Health Status Deterioration in Patients with Chronic Obstructive Pulmonary Disease
SPENCER, S., CALVERLEY, P. M. A., SHERWOOD BURGE, P., & JONES, P. W. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.2005009 · Cited by 334
Wijkstra, P., Van Altena, R., Kraan, J., Otten, V, Postma, D., & Koeter, G. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07020269 · Cited by 334
Ebrahim, S., & Smith, G. D. (1997) · BMJ · doi:10.1136/bmj.314.7095.1666 · Cited by 315
van der Valk, P., Monninkhof, E., van der Palen, J., Zielhuis, G., & van Herwaarden, C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-512oc · Cited by 298
Tashkin, D. P., Altose, M. D., Bleecker, E. R., Connett, J. E., Kanner, R. E., Lee, W. W., Wise, R., & The Lung Health Study Research Group 4 (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.2_pt_1.301 · Cited by 285
A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients
Chaouat, A., Weitzenblum, E., Kessler, R., Charpentier, C., Enrhart, M., Schott, R., Levi-Valensi, P., Zielinski, J., Delaunois, L., Cornudella, R., et al. (1999) · European Respiratory Journal · doi:10.1183/09031936.99.14510029 · Cited by 273
Hattotuwa, K. L., Gizycki, M. J., Ansari, T. W., Jeffery, P. K., & Barnes, N. C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2105025 · Cited by 270
RENNARD, S. I., ANDERSON, W., ZuWALLACK, R., BROUGHTON, J., BAILEY, W., FRIEDMAN, M., WISNIEWSKI, M., & RICKARD, K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.9903053 · Cited by 265
The Health Impact of Undiagnosed Airflow Obstruction in a National Sample of United States Adults
COULTAS, D. B., MAPEL, D., GAGNON, R., & LYDICK, E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2004029 · Cited by 251
Rossi, A., Kristufek, P., Levine, B. E., Thomson, M. H., Till, D., Kottakis, J., & Della Cioppa, G. (2002) · Chest · doi:10.1378/chest.121.4.1058 · Cited by 250
van Noord, J. A. (2000) · Thorax · doi:10.1136/thorax.55.4.289 · Cited by 249
Hospers, J. J., Postma, D. S., Rijcken, B., Weiss, S. T., & Schouten, J. P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02815-4 · Cited by 221
GARROD, R., MIKELSONS, C., PAUL, E. A., & WEDZICHA, J. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9912029 · Cited by 220
Weinberger, M., Murray, M. D., Marrero, D. G., Brewer, N., Lykens, M., Harris, L. E., Seshadri, R., Caffrey, H., Roesner, J. F., Smith, F., et al. (2002) · JAMA · doi:10.1001/jama.288.13.1594 · Cited by 215
Abdominal Muscle Use during Breathing in Patients with Chronic Airflow Obstruction
Ninane, V., Rypens, F., Yernault, J.-C., & de Troyer, A. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.1.16 · Cited by 214
van Noord, J. A., de Munck, D. R. A. J., Bantje, T. A., Hop, W. C. J., Akveld, M. L. M., & Bommer, A. M. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.15e11.x · Cited by 211
Chronic Airflow Limitation: Its Relationship to Work in Dusty Occupations
Becklake, M. R. (1985) · Chest · doi:10.1378/chest.88.4.608 · Cited by 205
Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study
Eaton, T., Garrett, J. E., Young, P., Fergusson, W., Kolbe, J., Rudkin, S., & Whyte, K. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00301002 · Cited by 203
Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study.
Kanner, R. E., Connett, J. E., Altose, M. D., Buist, A. S., Lee, W. W., Tashkin, D. P., & Wise, R. A. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.4.7921469 · Cited by 201
Noninvasive Positive Pressure Ventilation To Treat Respiratory Failure
Meyer, T. J., & Hill, N. S. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-9-199405010-00008 · Cited by 198
Bendstrup, K., Ingemann Jensen, J., Holm, S., & Bengtsson, B. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10122801 · Cited by 196
Fletcher, E. C., Luckett, R. A., Goodnight-White, S., Miller, C. C., Qian, W., & Costarangos-Galarza, C. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.5.1070 · Cited by 195
Guyatt, G. H., Townsend, M., So, P., Jl, K., Hd, S., Dw, T., & Newhouse, M. T. (1987) · PubMed · doi:10.1164/arrd.1987.135.5.1069 · Cited by 194
Results of a Home-Based Training Program for Patients With COPD
Hernández, M. T. E., Rubio, T. M., Ruiz, F. O., Riera, H. S., Gil, R. S., & Gómez, J. C. (2000) · Chest · doi:10.1378/chest.118.1.106 · Cited by 194
Hermiz, O. (2002) · BMJ · doi:10.1136/bmj.325.7370.938 · Cited by 190
Upper-Limb and Lower-Limb Exercise Training in Patients with Chronic Airflow Obstruction
Lake, F. R., Henderson, K., Briffa, T., Openshaw, J., & Musk, A. W. (1990) · Chest · doi:10.1378/chest.97.5.1077 · Cited by 187
Inhaled Corticosteroids Are Not Beneficial in Chronic Obstructive Pulmonary Disease
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.16125_2 · Cited by 185
Behnke, M., Taube, C., Kirsten, D., Lehnigk, B., Jörres, R., & MAGNUSSEN, H. (2000) · Respiratory Medicine · doi:10.1053/rmed.2000.0949 · Cited by 167
The Effectiveness of Outpatient Pulmonary Rehabilitation in Chronic Lung Disease
Finnerty, J. P., Keeping, I., Bullough, I., & Jones, J. (2001) · Chest · doi:10.1378/chest.119.6.1705 · Cited by 166
McDonald, C. F., Blyth, C. M., Lazarus, M. D., Marschner, I., & Barter, C. E. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.5.7582304 · Cited by 158
Alternative Mechanisms for Long-Acting β2-Adrenergic Agonists in COPD
Johnson, M., & Rennard, S. I. (2001) · CHEST Journal · doi:10.1378/chest.120.1.258 · Cited by 156
Nicotine replacement therapy in smoking cessation
Campbell, I. (2003) · Thorax · doi:10.1136/thorax.58.6.464 · Cited by 154
Aalbers, R., Ayres, J. G., Backer, V., Decramer, M., Lier, P. A., Magyar, P., Małolepszy, J., Ruffin, R. E., & Sybrecht, G. W. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00240902 · Cited by 153
Managed care: Disease management
Hunter, D. J., & Fairfield, G. (1997) · BMJ · doi:10.1136/bmj.315.7099.50 · Cited by 148
Routine Nebulized Ipratropium and Albuterol Together Are Better Than Either Alone in COPD
† (1997) · CHEST Journal · doi:10.1378/chest.112.6.1514 · Cited by 148
Cycle Ergometer and Inspiratory Muscle Training in Chronic Obstructive Pulmonary Disease
Larson, J. L., Covey, M. K., Wirtz, S., Berry, J. K., Alex, C. G., Langbein, W. E., & Edwards, L. C. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9804067 · Cited by 143
Intrinsic PEEP in Patients with Chronic Obstructive Pulmonary Disease: Role of Expiratory Muscles
Ninane, V., Yernault, J. C., & Troyer, A. D. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.4_pt_1.1037 · Cited by 143
Ringbæk, T., Broendum, E., HEMMINGSEN, L., Lybeck, K., Nielsen, D. S., ANDERSEN, C., & Lange, P. (2000) · Respiratory Medicine · doi:10.1053/rmed.1999.0704 · Cited by 140
Ketola, E., Sipilä, R., & Mäkelä, M. (2000) · Annals of Medicine · doi:10.3109/07853890009011767 · Cited by 135 · cited 1×
“A detailed evaluation of various smoking cessation methods and programs is beyond the scope of this article, but they are available elsewhere.(25-28) Although smoking cessation improves the natural history of COPD, once COPD becomes clinically apparent many sustained quitters remain symptomatic and their airways are p…”
BackgroundEvaluation of a self-management plan for chronic obstructive pulmonary disease
Watson, P., Town, G., Holbrook, N., Dwan, C., Toop, L., & Drennan, C. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10061267 · Cited by 132
Gallefoss, F., & Bakke, P. S. (2000) · Respiratory Medicine · doi:10.1053/rmed.1999.0749 · Cited by 128
Carl-Peter Engström, L.-O. P. (1999) · Scandinavian Journal of Rehabilitation Medicine · doi:10.1080/003655099444371 · Cited by 124
Jenkins, S. C., Heaton, R. W., Fulton, T. J., & Moxham, J. (1987) · CHEST Journal · doi:10.1378/chest.91.6.804 · Cited by 122
Bourbeau, J., Rouleau, M.-È., & Boucher, S. (1998) · Thorax · doi:10.1136/thx.53.6.477 · Cited by 120
Long-acting Inhaled β2-Agonist Therapy in Asthma
KIPS, J. C., & PAUWELS, R. A. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.6.2010107 · Cited by 117
Johnell, O., Pauwels, R., Lofdahl, C., Laitinen, L. A., Postma, D. S., Pride, N. B., & Ohlsson, S. V. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00276602 · Cited by 112
Oral theophylline for chronic obstructive pulmonary disease
Ram, F. S., Jones, P., Jardim, J. R., Castro, A. A., Atallah, Á. N., Lacasse, Y., Goldstein, R. S., & Cendon, S. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003902 · Cited by 110
Occurrence and Prognostic Significance of Ventricular Arrhythmia Is Related to Pulmonary Function
Engström, G., Wollmer, P., Hedblad, B., Juul‐Möller, S., Valind, S., & Janzon, L. (2001) · Circulation · doi:10.1161/01.cir.103.25.3086 · Cited by 102
Bałuk, P., & McDonald, D. M. (1994) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1994.266.4.l461 · Cited by 102
Inhaled Corticosteroids Are Beneficial in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.16125_1 · Cited by 101
Controlled trial of respiratory health worker visiting patients with chronic respiratory disability.
Cockcroft, A., Bagnall, P., Heslop, A., Andersson, N., Heaton, R., Batstone, J., Allen, J., Spencer, P. H., & Guz, A. (1987) · BMJ · doi:10.1136/bmj.294.6566.225 · Cited by 97
Goldstein, R. S., Todd, T. R. J., Guyatt, G., Keshavjee, S., Dolmage, T. E., van Rooy, S., Krip, B., Maltais, F., LeBlanc, P., Pakhale, S., et al. (2003) · Thorax · doi:10.1136/thorax.58.5.405 · Cited by 97
Littlejohns, P., Baveystock, C. M., Parnell, H., & Jones, P. (1991) · Thorax · doi:10.1136/thx.46.8.559 · Cited by 97
Vílkman, S., Keistinen, T., Tuuponen, T., & Kivelä, S. (2009) · Respiration · doi:10.1159/000196687 · Cited by 83
The impact of health care advice given in primary care on cardiovascular risk
Lindholm, L., Ekbom, T., Dash, C., Eriksson, M., Tibblin, G., & Scherstén, B. (1995) · BMJ · doi:10.1136/bmj.310.6987.1105 · Cited by 81
Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness
Verhoeven, G. T., Hegmans, J. P. J. J., Mulder, P. G. H., Bogaard, J. M., Hoogsteden, H. C., & Prins, J.-B. (2002) · Thorax · doi:10.1136/thorax.57.8.694 · Cited by 76
Self-help interventions for smoking cessation
Lancaster, T., & Stead, L. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001118 · Cited by 71
Exercise Training Improves Outcomes of a Dyspnea Self-management Program
Stulbarg, M. S., Carrieri‐Kohlman, V., Demir‐Deviren, S., Nguyen, H. Q., Adams, L., Tsang, A. H., Duda, J., Gold, W. M., & Paul, S. M. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200203000-00010 · Cited by 69
Weir, D. C., Bale, G., Bright, P., & Burge, P. S. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00021.x · Cited by 67
Chapman, K., Arvidsson, P., Chuchalin, A., Dhillon, D., Faurschou, P., Goldstein, R., & Kuipers, A. (2002) · Canadian Respiratory Journal · doi:10.1155/2002/493296 · Cited by 67
Yıldız, F., Kaur, A., Ilgazlı, A., Celikoglu, M., Özkara, S. K., Paksoy, N., & Özkarakaş, O. (2000) · Respiration · doi:10.1159/000029466 · Cited by 63
Persistence of the Effect of the Lung Health Study (LHS) Smoking Intervention over Eleven Years
Murray, R. P., Connett, J. E., Rand, C. S., Pan, W., & Anthonisen, N. R. (2002) · Preventive Medicine · doi:10.1006/pmed.2002.1087 · Cited by 62
Self-citationSilvestri, M., Fregonese, L., Sabatini, F., Dasic, G., & Rossi, G. A. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00067901 · Cited by 58
Domagala-Kulawik, J. J., Maskey‐Warzęchowska, M., Kraszewska, I., & Chazan, R. (2003) · CHEST Journal · doi:10.1378/chest.123.4.1054 · Cited by 56
Chronic bronchitis: The role of viruses
Hogg, J. C. (2000) · Seminars in Respiratory Infections · doi:10.1053/srin.2000.0150032 · Cited by 45
Sugiura, H., Ichinose, M., Yamagata, S., Koarai, A., Shirato, K., & Hattori, T. (2003) · Thorax · doi:10.1136/thorax.58.4.299 · Cited by 44
Ikeda, A., Nishimura, K., Koyama, H., Tsukino, M., Mishima, M., & Izumi, T. (1996) · Thorax · doi:10.1136/thx.51.1.48 · Cited by 44
Celli, B. R., Rassulo, J., & Corral, R. J. M. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.5.1276 · Cited by 32
Rescue! Therapy and the paradox of the Barcalounger
Rennard, S. I., & CALVERLEY, P. M. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00111602 · Cited by 16
(1999) · PubMed
Cited by
Azithromycin for prevention of exacerbations of COPD
Albert, R. K., Connett, J., Bailey, W. C., Casaburi, R., Cooper, J. A. D., Criner, G. J., Curtis, J. L., Dransfield, M. T., Han, M. K., Lazarus, S. C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104623 · Cited by 1,226
Self-citationPulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Troosters, T., Casaburi, R., Gosselink, R., & Decramer, M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1109so · Cited by 649
Integrated care programmes for chronically ill patients: a review of systematic reviews
Ouwens, M. (2005) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzi016 · Cited by 606
Schünemann, H. J., Jaeschke, R., Cook, D. J., Bria, W. F., El-Solh, A. A., Ernst, A., Fahy, B. F., Gould, M. K., Horan, K. L., Krishnan, J. A., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-197st · Cited by 577
Minimal Clinically Important Differences in COPD Lung Function
Donohue, J. F. (2005) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-200053377 · Cited by 529
Metadata
- Authors
- Sin, D. D., McAlister, F. A., Man, S. F. P., & Anthonisen, N. R.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-11-05
- Volume
- 290
- Issue
- 17
- Pages
- 2301
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2081714851
- Cited by
- 404
- References
- 131
- FWCI
- 25.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.